OA
WST icon

Oasis Advisors’s West Pharmaceutical WST Stock Holding History

Oasis Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,316
Closed -$330K – 231
2026
Q1 		$330K Buy
+1,316
New +$327K 0.06% 161

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Oasis Advisors's WST Position: Q2 2026 in Review

Oasis Advisors sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 1,316 shares — an estimated $330K sold.

Oasis Advisors first reported a position in WST in Q1 2026 and held it in 1 quarter. The position peaked at $330K in Q1 2026. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Oasis Advisors reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Oasis Advisors sold 1,316 West Pharmaceutical shares in Q2 2026, an estimated $330K.
  • Oasis Advisors first reported a position in West Pharmaceutical in Q1 2026 and held it in 1 quarter.
  • Oasis Advisors's West Pharmaceutical position peaked at $330K in Q1 2026.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Oasis Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.